A real-world, compassionate use programme of ocrelizumab in patients with primary progressive multiple sclerosis in Germany
Latest Information Update: 13 Jul 2021
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Expanded access
- 13 Jul 2021 New trial record